Lepu Medical Technology (Beijing) Co., Ltd. (300003.SZ) SHZ

12.39

-0.18(-1.43%)

Updated at June 03 03:04PM

Currency In CNY

Lepu Medical Technology (Beijing) Co., Ltd.

Address

37 Chaoqian Road

Beijing, 102200

China

Phone

86 10 8012 0666

Sector

Healthcare

Industry

Medical - Devices

Employees

8812

First IPO Date

October 30, 2009

Key Executives

NameTitlePayYear Born
Fei PuChief Executive Officer & Non Independent Director01989
Xiaoying FengDeputy General Manager01974
Zhongjie PuChairman & Chief Technology Officer01963
Bing Feng ZhangDeputy General Manager01980
Weina JiangSecretary of the Board01979
Zhan Jiang WeiSenior Deputy General Manager01972
Yong WangSenior VP & CFO01973

Description

Lepu Medical Technology (Beijing) Co., Ltd. develops, produces, and sells medical devices and equipment. The company offers cardiovascular interventional products, such as coronary stents and balloons, catheters, guide wires, introducer sheaths, tourniquets, inflation devices, and PCI accessories; structural heart diseases products, including occluders, vascular plugs, delivery systems, and mechanical heart valves; cardiac rhythm management products, which include pacemakers, equipment, leads, and electrophysiology; off-pump coronary artery bypass grafting surgical cardiology products; and PTA balloons and guide wires peripheral interventional products. It also provides critical care products, such as vascular access products, needle free connectors, blood samplers, and pressure transducers; floor and suspended type digital subtraction angiography systems; in vitro diagnostic equipment and biomarkers; hemodialysis catheters and hollow fiber dialyzers; and general surgery products, including surgical staplers and endo surgery accessories. In addition, the company offers cardiovascular system drugs, such as antithrombotic, hypolipidemic, antihypertensive, antianginal, and heart failure treatment; ß-lactamase antibiotics and antifungal antimicrobial drugs; central nervous system drugs comprises painkillers and antidepressants; gastric/duodenal ulcer and chronic liver disease treatment drugs; respiratory system drugs; hypoproteinemia drugs; and activating blood circulation drugs. Further, it provides precision medicine, ECG telemonitoring, and cardiovascular disease consulting and management center services; medical S&T incubation and equity investment, and medical financial services; consultation, online pharmacy, and household medical equipment services; smart devices; and specialized hospital services for cardiovascular diseases, as well as involved in the co-construction of Cath lab. The company was founded in 1999 and is headquartered in Beijing, China.